physostigmine has been researched along with Amblyopia, Developmental in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heintz, N; Hensch, TK; Miwa, JM; Morishita, H | 1 |
| Letson, RD | 1 |
1 review(s) available for physostigmine and Amblyopia, Developmental
| Article | Year |
|---|---|
The use of drugs in the management of strabismus.
Topics: Amblyopia; Amides; Atropine; Barbiturates; Bradycardia; Cataract; Central Nervous System; Chloral Hydrate; Cysts; Echothiophate Iodide; Fundus Oculi; Humans; Iris; Isoflurophate; Miotics; Mydriatics; Nitrophenols; Oculomotor Muscles; Phosphoric Acids; Physostigmine; Pilocarpine; Propionates; Quaternary Ammonium Compounds; Scopolamine; Strabismus; Tranquilizing Agents; Tropanes | 1970 |
1 other study(ies) available for physostigmine and Amblyopia, Developmental
| Article | Year |
|---|---|
Lynx1, a cholinergic brake, limits plasticity in adult visual cortex.
Topics: Adaptor Proteins, Signal Transducing; Aging; Amblyopia; Animals; Cholinesterase Inhibitors; Dominance, Ocular; Evoked Potentials, Visual; Mecamylamine; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Neuronal Plasticity; Neuropeptides; Nicotinic Antagonists; Physostigmine; Receptors, Nicotinic; Sensory Deprivation; Signal Transduction; Vision, Ocular; Visual Cortex; Visual Pathways | 2010 |